Development of new diagnostic tools and technologies: in vitro devices, assays and platforms
Development of new diagnostic tools and technologies: in vitro devices, assays and platforms
Last update: Nov 4, 2020
Last update: Nov 4, 2020
Development of new diagnostic tools and technologies: in vitro devices, assays and platforms
Last update: Nov 4, 2020

Details

Location:
EU 27
EU 27
Grantmaking entity type:
Development Institution
Status:
Awarded
Budget:
EUR 48,000,000
Award ceiling:
N/A
Award floor:
N/A
Sector:
Health, ICT & Telecommunications, Research & Innovation
Eligible applicants:
Unrestricted / Unspecified
Eligible applicant countries:
Afghanistan, Albania, Algeria, A ...
Afghanistan, Albania, Algeria, American Samoa, Angola, Anguilla, Argentina, Armenia, Aruba, Austria, Azerbaijan, Azores, Bangladesh, Belarus, Belgium, Belize, Benin, Bermuda, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, British Virgin Islands, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canary Islands, Cape Verde, Caribbean Netherlands, Cayman Islands, Central African Republic, Chad, Chile, Colombia, Comoros, Congo, Costa Rica, Cote d'Ivoire, Croatia, Cuba, Cyprus, Czech Republic, Dem. Rep. Congo, Denmark, Djibouti, Dominica, Commonwealth of, Dominican Republic, Ecuador, Egypt, El Salvador, Eritrea, Estonia, Eswatini (Swaziland), Ethiopia, Falkland Islands, Faroe Islands, Fiji, Finland, France, French Polynesia, French Southern Territory, Gabon, Gambia, Georgia, Germany, Ghana, Greece, Greenland, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Hungary, Iceland, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Jordan, Kazakhstan, Kenya, Kiribati, Kosovo, Kyrgyzstan, Laos, Latvia, Lebanon, Lesotho, Liberia, Libya, Lithuania, Luxembourg, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Mauritania, Mauritius, Micronesia, Moldova, Mongolia, Montenegro, Montserrat, Morocco, Mozambique, Myanmar, Namibia, Nepal, Netherlands, New Caledonia, Nicaragua, Niger, Nigeria, North Korea, North Macedonia, Norway, Pakistan, Palau, Palestine / West Bank & Gaza, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Pitcairn, Poland, Portugal, Romania, Rwanda, Saint Helena, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, Sao Tome and Principe, Senegal, Serbia, Seychelles, Sierra Leone, Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, South Sudan, Spain, Sri Lanka, St. Pierre and Miquelon, Sudan, Suriname, Sweden, Switzerland, Syria, Tajikistan, Tanzania, Thailand, Timor-Leste, Togo, Tonga, Tunisia, Türkiye, Turkmenistan, Turks and Caicos, Tuvalu, Uganda, Ukraine, Uruguay, Uzbekistan, Vanuatu, Venezuela, Vietnam, Wallis and Futuna, Yemen, Zambia, Zimbabwe
Date posted:
Dec 12, 2013

Attachments • 8

CORD.. .

Nov 4, 2020

CORD.. .

Sep 24, 2020

CORD.. .

Sep 22, 2020

CORD.. .

Sep 21, 2020

CORD.. .

Sep 18, 2020

CORD.. .

Jun 22, 2020

CORD.. .

Jun 15, 2020

CORD.. .

Jun 15, 2020

Associated Awards • 8

Dyna...
Poin...
Fast...
Geno...
Lase...
Chai...
Plat...
Adva...
Available with membership·See plans
Want to unlock full information?
Member-only information. Become a member to access this information. Procurement notices from over 850+ sources of tenders and grants published by donors, development banks, foundations, and international financial institutions (IFIs) are available here.

Description

Call updates:

20 November 2014 16:15

The submission session is now available for: PHC-10-2014(RIA)

Stage 2

The number of proposals submitted for this topic: PHC-10-2014=132

26 May 2014 15:49

The submission session is now available for: PHC-10-2014(RIA)

20 December 2013 16:39 The submission session is now available for: PHC-10-2014(RIA)


TOPIC : Development of new diagnostic tools and technologies: in vitro devices, assays and platforms

Topic identifier: PHC-10-2014
Publication date: 11 December 2013

Types of action: RIA Research and Innovation action
DeadlineModel:
Opening date:
two-stage
11 December 2013
Deadline:
2nd stage Deadline:
11 March 2014 17:00:00
19 August 2014 17:00:00

Time Zone : (Brussels time)
 
  Horizon 2020
Call identifier: H2020-PHC-2014-2015
Topic Description
Scope:

Specific challenge: The development of new diagnostics (more sensitive, robust and selective) for improved clinical practice demands the translation of multidisciplinary scientific and technological knowledge from diverse fields into clinical applications. Innovation in this area relies on the development, translation and uptake of existing, new or evolving and often complex technologies.

Improved clinical decisions based on new and improved diagnostic tools and techniques should lead to better health outcomes while contributing to the sustainability of the health care system.

This is also a field where many small European companies are active.         

Scope: Proposals should focus on the development and application of novel in vitro diagnostic tools and technologies (including assays and platforms). The novel application of existing tools and technologies is not included. These tools and technologies should improve the performance of diagnosis, prediction, monitoring, intervention or assessment of therapeutic response, with a significant impact on clinical decisions and health outcomes.

Additionally, proposals may include approaches based on high-throughput screening, nanotechnologies or microfluidics, data analysis methodology, or technologies for point-of-care diagnostics.    

The Commission considers that proposals requesting a contribution from the EU of between EUR 4 and 6 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.

Expected impact: This should provide:

         Innovative, more accurate, more reliable and cost effective in vitro diagnostic tools and technologies for earlier disease diagnosis, patient stratification and/or prognosis of disease outcome leading to improved clinical decisions and health outcomes.

         Contribution to the sustainability of health care systems.

         Growth of the European diagnostics sector, in particular for SMEs.           

Type of action: Research and innovation actions

Hidden

Market Intelligence

Discover the EU 27 market report

Explore key market trends, active sectors, major donors, and business opportunities across the development landscape.

View report
grant Background

About the Funding Agency

Horizon 2020 - is a Framework Programme for Research and Technological Development, and is created by the European Union in order to support and encourage research in the European Research Area (ERA). This is the biggest EU Research and Innovation programme ever with nearly €80 billion of funding available over 7 years (2014 to 2020). By coupling research and innovation, Horizon 2020 is helping to achieve this with its emphasis on excellent science, industrial leadership and tackling societal challenges. The goal is to ensure Europe produces world-class science, removes barriers to innovation and makes it easier for the public and private sectors to work together in delivering innovation. The Horizon 2020 programme running from 2014 to 2020 has a €79 billion budget (a 46% increase over FP7).

It is structured around three core pillars:

  • Excellent Science (~€24.4bn)
  • Industrial Leadership (~€17bn)
  • Societal Challenges (~€29.7bn)

Type of projects: mostly grants, no supplies, no works.

In order to see Horizon 2020 opportunities on DevelopmentAid, please click here.

About the Sectors

Health

Covers healthcare services, public health systems, and activities aimed at promoting physical and mental well-being.


Key areas:
  • Healthcare services and facilities
  • Public health and disease prevention
  • Medical equipment, supplies, and services

ICT & Telecommunications

Features information and communication technologies, digital systems, and telecommunications infrastructure and services.


Key areas:
  • ICT systems, software, and digital solutions
  • Telecommunications networks and services
  • Digitalization, data, and communication tools
Frequently Asked Questions
Haven't found what you're looking for? Get in touch with us using our contact page.
Where can I find international grant opportunities?
DevelopmentAid collects grant opportunities from bilateral donors, multilateral agencies, foundations, and international organizations in one centralized platform.
Who can apply for grants listed on DevelopmentAid?
Grants are typically open to NGOs, civil society organizations, research institutions, public entities, and sometimes private organizations or consortia.
Does DevelopmentAid help with grant applications?
DevelopmentAid does not write or submit applications, but it provides access to full call details, guidelines, deadlines, and donor information needed to apply.